The Repair Stem Cell Institute Invites Participation in a Unique Clinical Trial for COPD
The Repair Stem Cell Institute (RSCI) – http://www.repairstemcells.org -- is pleased to announce that it will assist interested patients to take part in a clinical trial based in the United States for the treatment of COPD (Chronic Obstructive Pulmonary Disease). The FDA approved and compliant trial, which uses adult stem cells, will be conducted only during January 2014 in the U.S. states of Florida and Georgia.
View full press release